BCL2 and cancer: Since the anti-apoptotic proteins HK-I, HK-II, Bcl-2, and Bcl-xL have been found to be expressed at high levels in many types of cancer [40,62,63,64,65,66,67], interfering with their interaction with VDAC1 is an appropriate target for inducing apoptosis.